Fusco J, Brunet L, Lackey P, Wohlfeiler M, Fusco G. An illustration of the impact of virologic failure definitions in clinical cohorts. Presented at: 23rd International Workshop on HIV and Hepatitis Observational Databases (IWHOD) 2019; Athens, Greece
Research Category: Abstracts and Posters
Characteristics of Early Adopters of a Two-Drug Regimen (Dolutegravir/Rilpivirine) for Treatment of Human Immunodeficiency Virus Type 1 in the United States
Pierone G, Schulman KL, Fusco J, et al. Characteristics of Early Adopters of a Two-Drug Regimen (Dolutegravir/Rilpivirine) for Treatment of Human Immunodeficiency Virus Type 1 in the United States. Presented at: AMCP Managed Care & Specialty Pharmacy Annual Meeting 2019; San Diego, CA, USA
Changes in Lipids After a Direct Switch from TDF to TAF
Mallon P, Brunet L, Fusco J, et al. Changes in Lipids After a Direct Switch from TDF to TAF [0652]. Presented at: Conference on Retroviruses and Opportunistic Infections (CROI) 2019; Seattle, WA
Characteristics of HIV+ Patients Prescribed Raltegravir QD in the United States
Lackey P, Schulman K, Fusco J, Arduino J, Prajapati G, Fusco G. Characteristics of HIV+ Patients Prescribed Raltegravir QD in the United States [555]. Presented at: IDWeek 2018; San Francisco, CA, USA
A Comprehensive Assessment of Hepatobiliary Disorders in HIV-Infected Patients Treated with Dolutegravir, Elvitegravir, Raltegravir or Darunavir in the OPERA Database
Wohlfeiler M, Mounzer K, Brunet L, et al. A Comprehensive Assessment of Hepatobiliary Disorders in HIV-Infected Patients Treated with Dolutegravir, Elvitegravir, Raltegravir or Darunavir in the OPERA Database. Presented at: 22nd International AIDS Conference 2018; Amsterdam, the Netherlands
Clinical Effectiveness of Guideline-Recommended Antiretroviral Therapy Core Agents in HIV/HCV Co-infected Patients in the OPERA Observational Database
Dieterich D, Brunet L, Fusco J, et al. Clinical Effectiveness of Guideline-Recommended Antiretroviral Therapy Core Agents in HIV/HCV Co-infected Patients in the OPERA Observational Database. Presented at: 22nd International AIDS Conference 2018; Amsterdam, the Netherlands
Identifying Heavily Treatment-Experienced Patients in the OPERA Cohort
Hsu R, Henegar C, Fusco J, et al. Identifying Heavily Treatment-Experienced Patients in the OPERA Cohort [THPEB044]. Presented at: 22nd AIDS International Conference; 2018; Amsterdam, the Netherlands
Virologic Outcomes Among Treatment Naïve HIV+ Patients Initiating Common First Antiretroviral Therapy Core Agents in the OPERA Observational Database
Mills A, Brunet L, Fusco J, et al. Virologic Outcomes Among Treatment Naïve HIV+ Patients Initiating Common First Antiretroviral Therapy Core Agents in the OPERA Observational Database [PEB039]. Presented at: 22nd International AIDS Conference; 2018; Amsterdam, the Netherlands
Benchmarking HIV Quality Measures in the US OPERA HIV Cohort
Heglar R, Mood R, Priest J, Schulman K, Fusco G. Benchmarking HIV Quality Measures in the US OPERA HIV Cohort. Presented at: ISPOR 2018; Baltimore, MD, USA
Clinical Effectiveness of Guideline-Recommended Antiretroviral Therapy Core Agents in HIV/HCV Coinfected Patients in the OPERA Observational Database
Dieterich D, Brunet L, Fusco J, et al. Clinical Effectiveness of Guideline-Recommended Antiretroviral Therapy Core Agents in HIV/HCV Coinfected Patients in the OPERA Observational Database. Paper presented at: 22nd International Workshop on HIV and Hepatitis Observational Databases (IWHOD) 2018; Fuengirola, Spain